Literature DB >> 17015513

Report of the Tennessee Task Force on Screening Newborn Infants for Critical Congenital Heart Disease.

Michael R Liske1, Christopher S Greeley, David J Law, Jonathan D Reich, William R Morrow, H Scott Baldwin, Thomas P Graham, Arnold W Strauss, Ann L Kavanaugh-McHugh, William F Walsh.   

Abstract

A member of the Tennessee state legislature recently proposed a bill that would mandate all newborn infants to undergo pulse oximetry screening for the purpose of identifying those with critical structural heart disease before discharge home. The Tennessee Task Force on Screening Newborn Infants for Critical Congenital Heart Defects was convened on September 29, 2005. This group reviewed the current medical literature on this topic, as well as data obtained from the Tennessee Department of Health, and debated the merits and potential detriments of a statewide screening program. The estimated incidence of critical congenital heart disease is 170 in 100,000 live births, and of those, 60 in 100,000 infants have ductal-dependent left-sided obstructive lesions with the potential of presentation by shock or death if the diagnosis is missed. Of the latter group, the diagnosis is missed in approximately 9 in 100,000 by fetal ultrasound assessment and discharge examination and might be identified by a screening program. Identification of the missed diagnosis in these infants before discharge could spare many of them death or neurologic sequelae. Four major studies using pulse oximetry screening were analyzed, and when data were restricted to critical left-sided obstructive lesions, sensitivity values of 0% to 50% and false-positive rates of between 0.01% and 12% were found in asymptomatic populations. Because of this variability and other considerations, a meaningful cost/benefit analysis could not be performed. It was the consensus of the task force to provide a recommendation to the legislature that mandatory screening not be implemented at this time. In addition, we determined that a very large, prospective, perhaps multistate study is needed to define the sensitivity and false-positive rates of lower-limb pulse oximetry screening in the asymptomatic newborn population and that there needs to be continued partnering between the medical community, parents, and local, state, and national governments in decisions regarding mandated medical care.

Entities:  

Mesh:

Year:  2006        PMID: 17015513     DOI: 10.1542/peds.2005-3061

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Screening newborns for congenital heart disease with pulse oximetry: survey of pediatric cardiologists.

Authors:  Ruey-Kang R Chang; Sandra Rodriguez; Thomas S Klitzner
Journal:  Pediatr Cardiol       Date:  2008-07-25       Impact factor: 1.655

2.  A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.

Authors:  Cora Peterson; Scott D Grosse; Jill Glidewell; Lorraine F Garg; Kim Van Naarden Braun; Mary M Knapp; Leslie M Beres; Cynthia F Hinton; Richard S Olney; Cynthia H Cassell
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

3.  The reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants.

Authors:  J D Reich; B Connolly; G Bradley; S Littman; W Koeppel; P Lewycky; M Liske
Journal:  Pediatr Cardiol       Date:  2008-09       Impact factor: 1.655

4.  Evaluating the diagnostic gap: statewide incidence of undiagnosed critical congenital heart disease before newborn screening with pulse oximetry.

Authors:  Jessica H Mouledoux; William F Walsh
Journal:  Pediatr Cardiol       Date:  2013-04-18       Impact factor: 1.655

5.  Blood pressure screening for critical congenital heart disease in neonates.

Authors:  Kristi L Boelke; John S Hokanson
Journal:  Pediatr Cardiol       Date:  2014-06-05       Impact factor: 1.655

6.  Reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants: the importance of human factors.

Authors:  J D Reich; B Connolly; G Bradley; S Littman; W Koeppel; P Lewycky; M Liske
Journal:  Pediatr Cardiol       Date:  2007-10-12       Impact factor: 1.655

Review 7.  Universal Pulse Oximetry Screening for Early Detection of Critical Congenital Heart Disease.

Authors:  Praveen Kumar
Journal:  Clin Med Insights Pediatr       Date:  2016-06-01

8.  Modern Strategy for Identification of Congenital Heart Defects in the Neonatal Period.

Authors:  Mediha Kardasevic; Ida Jovanovic; Jelica Predojevic Samardzic
Journal:  Med Arch       Date:  2016-10-25

9.  Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China.

Authors:  Ruoyan Gai Tobe; Gerard R Martin; Fuhai Li; Akinori Moriichi; Bin Wu; Rintaro Mori
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

10.  A novel, more efficient, staged approach for critical congenital heart disease screening.

Authors:  J Mouledoux; S Guerra; J Ballweg; Y Li; W Walsh
Journal:  J Perinatol       Date:  2016-11-10       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.